SCHEMBL13487477

SCHEMBL13487477

Cc1ccc2c(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3ccccc3c(-c3ccc4c(c3)-c3ccccc3C4(C)C)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
NPSR1 Q6W5P4 4/20 0.35
ATM Q13315 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
XBP1 P17861 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 6/20 0.35
ABCG2 Q9UNQ0 2/20 0.35
ABCB1 P08183 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 4/20 0.34
TP53 P04637 2/20 0.34
PDK2 Q15119 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP1B1 Q16678 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
ALDH1A1 P00352 6/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487848 0.93 PDK2 (0.36) MEN1KMT2ANPSR1ATMNPC1
SCHEMBL13487548 0.91 MEN1 (0.34) MEN1KMT2AATMMAPTLMNA
SCHEMBL13487476 0.90 ALDH1A1 (0.39) MEN1KMT2ANPSR1ATMNPC1
SCHEMBL13487793 0.89 MEN1 (0.35) MEN1KMT2AATMMAPTLMNA
SCHEMBL13487442 0.87 PDK2 (0.36) NPSR1ATMRAB9ASMN1; SMN2LMNA
SCHEMBL13487631 0.87 ALDH1A1 (0.36) MEN1KMT2AATMMAPTSMN1; SMN2
SCHEMBL13487682 0.87 MEN1 (0.34) MEN1KMT2AATMMAPTSMN1; SMN2
SCHEMBL13487474 0.87 MEN1 (0.40) MEN1KMT2ANPSR1MAPTLMNA
SCHEMBL13487462 0.86 NQO2 (0.37) MEN1KMT2ANPSR1ATMNPC1
SCHEMBL17151901 0.86 MEN1 (0.37) MEN1KMT2ANPSR1ATMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 MEN1 3017/4885KMT2A 3530/4885NPSR1 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.